{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:49:17Z","timestamp":1774788557998,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,29]]},"DOI":"10.7759\/cureus.106064","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:21:21Z","timestamp":1774786881000},"source":"Crossref","is-referenced-by-count":0,"title":["Curative-Intent Chemoimmunotherapy in Stage IIB Triple-Negative Breast Cancer in a Patient on Chronic Peritoneal Dialysis: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Maria","family":"Jamil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Jabbour-Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javairia","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes WD","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010, 363:1938-48. 10.1056\/NEJMra1001389","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent R","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, et al.. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13:4429-34. 10.1158\/1078-0432.CCR-06-3045","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar P","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al.. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014, 384:164-72. 10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid P","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, et al.. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020, 382:810-21. 10.1056\/NEJMoa1910549","journal-title":"N Engl J Med"},{"key":"ref5","unstructured":"USRDS 2023 Annual Data Report. epidemiology of kidney disease in the United States. (2023). Accessed: February 24, 2026: https:\/\/usrds-adr.niddk.nih.gov\/2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001912","article-title":"Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts","volume":"70","author":"Mujais S","year":"2006","unstructured":"Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl. 2006, 70:S21-6. 10.1038\/sj.ki.5001912","journal-title":"Kidney Int Suppl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert AH","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA, et al.. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989, 7:1748-56. 10.1200\/JCO.1989.7.11.1748","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605979","article-title":"Cancer and renal insufficiency results of the BIRMA study","volume":"103","author":"Janus N","year":"2010","unstructured":"Janus N, Launay-Vacher V, Byloos E, et al.. Cancer and renal insufficiency results of the BIRMA study. Br J Cancer. 2010, 103:1815-21. 10.1038\/sj.bjc.6605979","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.1.2.107.62910","article-title":"Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy","volume":"1","author":"Scripture CD","year":"2005","unstructured":"Scripture CD, Figg WD, Sparreboom A. Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy. Ther Clin Risk Manag. 2005, 1:107-14. 10.2147\/tcrm.1.2.107.62910","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","unstructured":"KEYTRUDA (pembrolizumab) prescribing information. (2023). Accessed. February 24, 2026: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/k\/keytruda\/keytruda_pi.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti G","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004, 56:185-229. 10.1124\/pr.56.2.6","journal-title":"Pharmacol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00548589","article-title":"Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites","volume":"19","author":"Juma FD","year":"1981","unstructured":"Juma FD, Rogers HJ, Trounce JR. Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites. Eur J Clin Pharmacol. 1981, 19:443-51. 10.1007\/BF00548589","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans WF","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, et al.. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007, 25:4414-22. 10.1200\/JCO.2007.10.6823","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar FB","year":"2016","unstructured":"Cortazar FB, Marrone KA, Troxell ML, et al.. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016, 90:638-47. 10.1016\/j.kint.2016.04.008","journal-title":"Kidney Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467720-curative-intent-chemoimmunotherapy-in-stage-iib-triple-negative-breast-cancer-in-a-patient-on-chronic-peritoneal-dialysis-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:21:22Z","timestamp":1774786882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467720-curative-intent-chemoimmunotherapy-in-stage-iib-triple-negative-breast-cancer-in-a-patient-on-chronic-peritoneal-dialysis-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.106064","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}